Literature DB >> 16183517

Exogenous reinfection in tuberculosis.

Chen-Yuan Chiang1, Lee W Riley.   

Abstract

Whether the development of active tuberculosis in people with previous tuberculous infection represents an episode of endogenous reactivation or exogenous reinfection has been debated for decades. Articles proposing the unitary concept of pathogenesis of tuberculosis in the 1960s initiated a period in which reinfection was considered to be an uncommon cause of tuberculosis. To review evidence demonstrating the occurrence of tuberculosis due to exogenous reinfection, we did a literature search covering publications from 1966 until the present, and found that there was substantial evidence--both experimental and epidemiological--supporting the role of exogenous reinfection in tuberculosis. However, only models based on estimates of the annual risk of infection and the incidence of tuberculosis provided a quantitative estimate of the relative contribution of exogenous reinfection to the burden of tuberculosis. Better estimates of the contribution of exogenous reinfection to new cases of tuberculosis may need to be considered in tuberculosis control strategies.

Entities:  

Mesh:

Year:  2005        PMID: 16183517     DOI: 10.1016/S1473-3099(05)70240-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  46 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.

Authors:  Ted Cohen; Caroline Colijn; Bryson Finklea; Megan Murray
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

Review 3.  Endobronchial tuberculosis: an overview.

Authors:  Q Xue; N Wang; X Xue; J Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-16       Impact factor: 3.267

Review 4.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

Review 5.  Tuberculosis vaccine types and timings.

Authors:  Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

6.  Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.

Authors:  Juan Manuel Cubillos-Angulo; María B Arriaga; Elisângela C Silva; Beatriz L A Müller; Daniela M P Ramalho; Kiyoshi F Fukutani; Pryscila F C Miranda; Adriana S R Moreira; Antonio Ruffino-Netto; Jose R Lapa E Silva; Timothy R Sterling; Afrânio L Kritski; Martha M Oliveira; Bruno B Andrade
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

Review 7.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Guinea pig model of Mycobacterium tuberculosis latent/dormant infection.

Authors:  Suely S Kashino; Danielle R Napolitano; Ziedonis Skobe; Antonio Campos-Neto
Journal:  Microbes Infect       Date:  2008-09-06       Impact factor: 2.700

9.  The emergence of latent infection in the early evolution of Mycobacterium tuberculosis.

Authors:  Rebecca H Chisholm; Mark M Tanaka
Journal:  Proc Biol Sci       Date:  2016-05-25       Impact factor: 5.349

10.  The transmission dynamics of tuberculosis in a recently developed Chinese city.

Authors:  Peng Wu; Eric H Y Lau; Benjamin J Cowling; Chi-Chiu Leung; Cheuk-Ming Tam; Gabriel M Leung
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.